Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitut...
Gespeichert in:
Veröffentlicht in: | JACC. Case reports 2022-06, Vol.4 (12), p.751-754 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 754 |
---|---|
container_issue | 12 |
container_start_page | 751 |
container_title | JACC. Case reports |
container_volume | 4 |
creator | Jeelani, Hafiz Sheikh, Muhammad Mubbashir Tahir, Nayha Ying, Grace Prasad, Sonika Yaremko, Maryana Gill, Jashan |
description | Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (
Level of Difficulty: Intermediate.
) |
doi_str_mv | 10.1016/j.jaccas.2022.01.027 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2677-7ae599a3ef581dca448ad33eb0c5b4966979dbf98c89171db58430ca2d1bcbef3</originalsourceid><addsrcrecordid>eNpVkc1KAzEUhYMoVmrfwEVeYMYk85uNMJRqC4W60HW4-ZlpyjRTkkyhb29rRXR1D1zOdxYfQk-UpJTQ8nmX7kApCCkjjKWEpoRVN-iBlWWZkDrnt3_yBM1C2BFCWEEp5eweTbKiyvKC1Q_otDZtxE30FnrcHA7GaegM3ijVj8EODkPA4HDTR-MdRHs0OA64cdGqAbqxBxcDtg6vpB-jdVYmK6dHZTRemv3g_RY6q_C78VaB15eRRdt-kx_RXQt9MLOfO0Wfr4uP-TJZb95W82adKFZWVVKBKTiHzLRFTbWCPK9BZ5mRRBUy52XJK65ly2tVc1pRLYs6z4gCpqlU0rTZFL1cuYdR7o1WxkUPvTh4uwd_EgNY8f_j7FZ0w1FwRipelGdAfgUoP4TgTfvbpURcbIiduNoQFxuCUHG2kX0BY_6B8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Jeelani, Hafiz ; Sheikh, Muhammad Mubbashir ; Tahir, Nayha ; Ying, Grace ; Prasad, Sonika ; Yaremko, Maryana ; Gill, Jashan</creator><creatorcontrib>Jeelani, Hafiz ; Sheikh, Muhammad Mubbashir ; Tahir, Nayha ; Ying, Grace ; Prasad, Sonika ; Yaremko, Maryana ; Gill, Jashan</creatorcontrib><description>Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (
Level of Difficulty: Intermediate.
)</description><identifier>ISSN: 2666-0849</identifier><identifier>EISSN: 2666-0849</identifier><identifier>DOI: 10.1016/j.jaccas.2022.01.027</identifier><identifier>PMID: 35734528</identifier><language>eng</language><publisher>Elsevier</publisher><subject>Case Report</subject><ispartof>JACC. Case reports, 2022-06, Vol.4 (12), p.751-754</ispartof><rights>2022 The Authors 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2677-7ae599a3ef581dca448ad33eb0c5b4966979dbf98c89171db58430ca2d1bcbef3</citedby><cites>FETCH-LOGICAL-c2677-7ae599a3ef581dca448ad33eb0c5b4966979dbf98c89171db58430ca2d1bcbef3</cites><orcidid>0000-0002-9010-3569</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207956/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207956/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Jeelani, Hafiz</creatorcontrib><creatorcontrib>Sheikh, Muhammad Mubbashir</creatorcontrib><creatorcontrib>Tahir, Nayha</creatorcontrib><creatorcontrib>Ying, Grace</creatorcontrib><creatorcontrib>Prasad, Sonika</creatorcontrib><creatorcontrib>Yaremko, Maryana</creatorcontrib><creatorcontrib>Gill, Jashan</creatorcontrib><title>Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion</title><title>JACC. Case reports</title><description>Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (
Level of Difficulty: Intermediate.
)</description><subject>Case Report</subject><issn>2666-0849</issn><issn>2666-0849</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkc1KAzEUhYMoVmrfwEVeYMYk85uNMJRqC4W60HW4-ZlpyjRTkkyhb29rRXR1D1zOdxYfQk-UpJTQ8nmX7kApCCkjjKWEpoRVN-iBlWWZkDrnt3_yBM1C2BFCWEEp5eweTbKiyvKC1Q_otDZtxE30FnrcHA7GaegM3ijVj8EODkPA4HDTR-MdRHs0OA64cdGqAbqxBxcDtg6vpB-jdVYmK6dHZTRemv3g_RY6q_C78VaB15eRRdt-kx_RXQt9MLOfO0Wfr4uP-TJZb95W82adKFZWVVKBKTiHzLRFTbWCPK9BZ5mRRBUy52XJK65ly2tVc1pRLYs6z4gCpqlU0rTZFL1cuYdR7o1WxkUPvTh4uwd_EgNY8f_j7FZ0w1FwRipelGdAfgUoP4TgTfvbpURcbIiduNoQFxuCUHG2kX0BY_6B8A</recordid><startdate>20220615</startdate><enddate>20220615</enddate><creator>Jeelani, Hafiz</creator><creator>Sheikh, Muhammad Mubbashir</creator><creator>Tahir, Nayha</creator><creator>Ying, Grace</creator><creator>Prasad, Sonika</creator><creator>Yaremko, Maryana</creator><creator>Gill, Jashan</creator><general>Elsevier</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9010-3569</orcidid></search><sort><creationdate>20220615</creationdate><title>Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion</title><author>Jeelani, Hafiz ; Sheikh, Muhammad Mubbashir ; Tahir, Nayha ; Ying, Grace ; Prasad, Sonika ; Yaremko, Maryana ; Gill, Jashan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2677-7ae599a3ef581dca448ad33eb0c5b4966979dbf98c89171db58430ca2d1bcbef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeelani, Hafiz</creatorcontrib><creatorcontrib>Sheikh, Muhammad Mubbashir</creatorcontrib><creatorcontrib>Tahir, Nayha</creatorcontrib><creatorcontrib>Ying, Grace</creatorcontrib><creatorcontrib>Prasad, Sonika</creatorcontrib><creatorcontrib>Yaremko, Maryana</creatorcontrib><creatorcontrib>Gill, Jashan</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JACC. Case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeelani, Hafiz</au><au>Sheikh, Muhammad Mubbashir</au><au>Tahir, Nayha</au><au>Ying, Grace</au><au>Prasad, Sonika</au><au>Yaremko, Maryana</au><au>Gill, Jashan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion</atitle><jtitle>JACC. Case reports</jtitle><date>2022-06-15</date><risdate>2022</risdate><volume>4</volume><issue>12</issue><spage>751</spage><epage>754</epage><pages>751-754</pages><issn>2666-0849</issn><eissn>2666-0849</eissn><abstract>Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (
Level of Difficulty: Intermediate.
)</abstract><pub>Elsevier</pub><pmid>35734528</pmid><doi>10.1016/j.jaccas.2022.01.027</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-9010-3569</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2666-0849 |
ispartof | JACC. Case reports, 2022-06, Vol.4 (12), p.751-754 |
issn | 2666-0849 2666-0849 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207956 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Case Report |
title | Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A58%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Left%20Atrial%20Appendage%20Occlusion%20as%20an%20Alternative%20to%20Anticoagulants%20in%20Ibrutinib-Induced%20Hemorrhagic%20Pericardial%20Effusion&rft.jtitle=JACC.%20Case%20reports&rft.au=Jeelani,%20Hafiz&rft.date=2022-06-15&rft.volume=4&rft.issue=12&rft.spage=751&rft.epage=754&rft.pages=751-754&rft.issn=2666-0849&rft.eissn=2666-0849&rft_id=info:doi/10.1016/j.jaccas.2022.01.027&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_9207956%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35734528&rfr_iscdi=true |